Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Oussama Wazni, MD, is a Staff Physician in the Cleveland Clinic Section of Cardiac Electrophysiology and Pacing. He is the Director of the Outpatient Electrophysiology Department and Co-Director of the Ventricular Arrhythmia Center. He is board-certified in internal medicine, cardiology and cardiac electrophysiology. He specializes in electrophysiology with special interest in atrial fibrillation and ventricular tachycardia ablation.
Dr. Wazni received a Bachelor's degree in Sciences/Biology from the American University of Beirut, continuing there to complete his medical degree, graduating with distinction in the top 5 percent of his class. He was inducted into the Alpha Omega Alpha Medical Honor Society. After completing his residency at Cleveland Clinic, Dr Wazni received a fellowship in cardiology from the University of Texas, Houston, where he became Fellow of the Year. He then returned to Cleveland Clinic for fellowships in cardiology and electrophysiology, becoming Chief Fellow in electrophysiology.
He was a finalist in the Young Investigator Award presented by the American College of Cardiology in 2004 and, that same year, won the Clinical Research Award from the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.
Dr. Wazni is principal investigator in several ongoing research studies related to atrial fibrillation and ventricular tachycardia ablation, anticoagulation management in patients undergoing ablation for chronic atrial fibrillation, and use of low molecular heparin for bridging in patients undergoing implantation of mechanical valves.
Widely published in peer-reviewed journals, Dr. Wazni is on the editorial board of the Journal of the American College of Cardiology and the Journal of Cardiovascular Electrophysiology. He served as the Abstract Session Chair for the Heart Rhythm Society's Scientific Sessions in 2005 and 2006.
Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Ventricular Tachycardia, Biventricular Pacemaker, Catheter Ablation, Lead Extraction, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/8/2012, Dr. Wazni has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.